From Name:
From Email:
To Name:
To Email:

Optional Message:


Dabigatran Reversal Drug Holds Promise

from MedPage Today

While treatment with dabigatran among patients diagnosed with atrial fibrillation is known to reduce the risk of stroke, researchers said the long half-life of the anticoagulant concerns doctors when patients on the drug need other treatments. But a new medication may hold the key to reversing the bleeding complications. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063